Atsushi Niida, Takanori Hasegawa, Hideki Innan, Tatsuhiro Shibata, Koshi Mimori, Satoru Miyano. PeerJ 2020
Times Cited: 4
Times Cited: 4
Times Cited
Times Co-cited
Similarity
A progenitor cell origin of myeloid malignancies.
Hiroshi Haeno, Ross L Levine, D Gary Gilliland, Franziska Michor. Proc Natl Acad Sci U S A 2009
Hiroshi Haeno, Ross L Levine, D Gary Gilliland, Franziska Michor. Proc Natl Acad Sci U S A 2009
25
Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b.
Graham R Foster. Drugs 2010
Graham R Foster. Drugs 2010
25
Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons.
Eric M Pietras, Ranjani Lakshminarasimhan, Jose-Marc Techner, Sarah Fong, Johanna Flach, Mikhail Binnewies, Emmanuelle Passegué. J Exp Med 2014
Eric M Pietras, Ranjani Lakshminarasimhan, Jose-Marc Techner, Sarah Fong, Johanna Flach, Mikhail Binnewies, Emmanuelle Passegué. J Exp Med 2014
25
Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project.
Giovanni Barosi, Ruben Mesa, Guido Finazzi, Claire Harrison, Jean-Jacques Kiladjian, Eva Lengfelder, Mary F McMullin, Francesco Passamonti, Alessandro M Vannucchi, Carlos Besses,[...]. Blood 2013
Giovanni Barosi, Ruben Mesa, Guido Finazzi, Claire Harrison, Jean-Jacques Kiladjian, Eva Lengfelder, Mary F McMullin, Francesco Passamonti, Alessandro M Vannucchi, Carlos Besses,[...]. Blood 2013
25
Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha.
Steven W Lane, Ann Mullaly. Oncotarget 2013
Steven W Lane, Ann Mullaly. Oncotarget 2013
25
Bone marrow and the control of immunity.
Ende Zhao, Huanbin Xu, Lin Wang, Ilona Kryczek, Ke Wu, Yu Hu, Guobin Wang, Weiping Zou. Cell Mol Immunol 2012
Ende Zhao, Huanbin Xu, Lin Wang, Ilona Kryczek, Ke Wu, Yu Hu, Guobin Wang, Weiping Zou. Cell Mol Immunol 2012
25
Population pharmacokinetic-pharmacodynamic modeling and simulation of platelet decrease induced by peg-interferon-alpha 2a.
Tomohisa Saito, Satofumi Iida, Takehiko Kawanishi. Drug Metab Pharmacokinet 2012
Tomohisa Saito, Satofumi Iida, Takehiko Kawanishi. Drug Metab Pharmacokinet 2012
50
High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a.
Jean-Jacques Kiladjian, Bruno Cassinat, Pascal Turlure, Nathalie Cambier, Murielle Roussel, Sylvia Bellucci, Marie-Laurence Menot, Gerald Massonnet, Jean-Luc Dutel, Kamel Ghomari,[...]. Blood 2006
Jean-Jacques Kiladjian, Bruno Cassinat, Pascal Turlure, Nathalie Cambier, Murielle Roussel, Sylvia Bellucci, Marie-Laurence Menot, Gerald Massonnet, Jean-Luc Dutel, Kamel Ghomari,[...]. Blood 2006
25
Dissecting cancer through mathematics: from the cell to the animal model.
Helen M Byrne. Nat Rev Cancer 2010
Helen M Byrne. Nat Rev Cancer 2010
25
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
Roberto Marchioli, Guido Finazzi, Raffaele Landolfi, Jack Kutti, Heinz Gisslinger, Carlo Patrono, Raphael Marilus, Ana Villegas, Gianni Tognoni, Tiziano Barbui. J Clin Oncol 2005
Roberto Marchioli, Guido Finazzi, Raffaele Landolfi, Jack Kutti, Heinz Gisslinger, Carlo Patrono, Raphael Marilus, Ana Villegas, Gianni Tognoni, Tiziano Barbui. J Clin Oncol 2005
25
Interferons in hematopoiesis and leukemia.
Christian M Schürch, Carsten Riether, Adrian F Ochsenbein. Oncoimmunology 2013
Christian M Schürch, Carsten Riether, Adrian F Ochsenbein. Oncoimmunology 2013
25
Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a.
Alfonso Quintás-Cardama, Omar Abdel-Wahab, Taghi Manshouri, Outi Kilpivaara, Jorge Cortes, Anne-Laure Roupie, Su-Jiang Zhang, David Harris, Zeev Estrov, Hagop Kantarjian,[...]. Blood 2013
Alfonso Quintás-Cardama, Omar Abdel-Wahab, Taghi Manshouri, Outi Kilpivaara, Jorge Cortes, Anne-Laure Roupie, Su-Jiang Zhang, David Harris, Zeev Estrov, Hagop Kantarjian,[...]. Blood 2013
25
Comparative long-term effects of interferon α and hydroxyurea on human hematopoietic progenitor cells.
Katherine Y King, Katie A Matatall, Ching-Chieh Shen, Margaret A Goodell, Sabina I Swierczek, Josef T Prchal. Exp Hematol 2015
Katherine Y King, Katie A Matatall, Ching-Chieh Shen, Margaret A Goodell, Sabina I Swierczek, Josef T Prchal. Exp Hematol 2015
25
The three Es of cancer immunoediting.
Gavin P Dunn, Lloyd J Old, Robert D Schreiber. Annu Rev Immunol 2004
Gavin P Dunn, Lloyd J Old, Robert D Schreiber. Annu Rev Immunol 2004
25
Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms.
Rasmus K Pedersen, Morten Andersen, Trine A Knudsen, Zamra Sajid, Johanne Gudmand-Hoeyer, Marc J B Dam, Vibe Skov, Lasse Kjaer, Christina Ellervik, Thomas S Larsen,[...]. Cancer Med 2020
Rasmus K Pedersen, Morten Andersen, Trine A Knudsen, Zamra Sajid, Johanne Gudmand-Hoeyer, Marc J B Dam, Vibe Skov, Lasse Kjaer, Christina Ellervik, Thomas S Larsen,[...]. Cancer Med 2020
25
How common are myeloproliferative neoplasms? A systematic review and meta-analysis.
Glen J Titmarsh, Andrew S Duncombe, Mary Frances McMullin, Michael O'Rorke, Ruben Mesa, Frank De Vocht, Sarah Horan, Lin Fritschi, Mike Clarke, Lesley A Anderson. Am J Hematol 2014
Glen J Titmarsh, Andrew S Duncombe, Mary Frances McMullin, Michael O'Rorke, Ruben Mesa, Frank De Vocht, Sarah Horan, Lin Fritschi, Mike Clarke, Lesley A Anderson. Am J Hematol 2014
25
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development.
Morten Andersen, Zamra Sajid, Rasmus K Pedersen, Johanne Gudmand-Hoeyer, Christina Ellervik, Vibe Skov, Lasse Kjær, Niels Pallisgaard, Torben A Kruse, Mads Thomassen,[...]. PLoS One 2017
Morten Andersen, Zamra Sajid, Rasmus K Pedersen, Johanne Gudmand-Hoeyer, Christina Ellervik, Vibe Skov, Lasse Kjær, Niels Pallisgaard, Torben A Kruse, Mads Thomassen,[...]. PLoS One 2017
25
Mathematical analysis of the Cancitis model and the role of inflammation in blood cancer progression.
Zamra Sajid, Morten Andersen, Johnny T Ottesen. Math Biosci Eng 2019
Zamra Sajid, Morten Andersen, Johnny T Ottesen. Math Biosci Eng 2019
50
Cell division patterns in acute myeloid leukemia stem-like cells determine clinical course: a model to predict patient survival.
Thomas Stiehl, Natalia Baran, Anthony D Ho, Anna Marciniak-Czochra. Cancer Res 2015
Thomas Stiehl, Natalia Baran, Anthony D Ho, Anna Marciniak-Czochra. Cancer Res 2015
25
25
Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway.
Christina Roaldsnes, René Holst, Henrik Frederiksen, Waleed Ghanima. Eur J Haematol 2017
Christina Roaldsnes, René Holst, Henrik Frederiksen, Waleed Ghanima. Eur J Haematol 2017
25
Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone.
J-J Kiladjian, S Giraudier, B Cassinat. Leukemia 2016
J-J Kiladjian, S Giraudier, B Cassinat. Leukemia 2016
25
Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells.
Min Tang, Mithat Gonen, Alfonso Quintas-Cardama, Jorge Cortes, Hagop Kantarjian, Chani Field, Timothy P Hughes, Susan Branford, Franziska Michor. Blood 2011
Min Tang, Mithat Gonen, Alfonso Quintas-Cardama, Jorge Cortes, Hagop Kantarjian, Chani Field, Timothy P Hughes, Susan Branford, Franziska Michor. Blood 2011
25
Successful therapy must eradicate cancer stem cells.
David Dingli, Franziska Michor. Stem Cells 2006
David Dingli, Franziska Michor. Stem Cells 2006
25
Global dynamics of healthy and cancer cells competing in the hematopoietic system.
Morten Andersen, Hans C Hasselbalch, Lasse Kjær, Vibe Skov, Johnny T Ottesen. Math Biosci 2020
Morten Andersen, Hans C Hasselbalch, Lasse Kjær, Vibe Skov, Johnny T Ottesen. Math Biosci 2020
33
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko,[...]. Lancet Haematol 2020
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko,[...]. Lancet Haematol 2020
25
Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report.
Ayalew Tefferi, Francisco Cervantes, Ruben Mesa, Francesco Passamonti, Srdan Verstovsek, Alessandro M Vannucchi, Jason Gotlib, Brigitte Dupriez, Animesh Pardanani, Claire Harrison,[...]. Blood 2013
Ayalew Tefferi, Francisco Cervantes, Ruben Mesa, Francesco Passamonti, Srdan Verstovsek, Alessandro M Vannucchi, Jason Gotlib, Brigitte Dupriez, Animesh Pardanani, Claire Harrison,[...]. Blood 2013
25
Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study.
R Bruno, P Sacchi, C Scagnolari, F Torriani, L Maiocchi, S Patruno, F Bellomi, G Filice, G Antonelli. Aliment Pharmacol Ther 2007
R Bruno, P Sacchi, C Scagnolari, F Torriani, L Maiocchi, S Patruno, F Bellomi, G Filice, G Antonelli. Aliment Pharmacol Ther 2007
25
25
Determining the role of inflammation in the selection of JAK2 mutant cells in myeloproliferative neoplasms.
Jie Zhang, Angela G Fleischman, Dominik Wodarz, Natalia L Komarova. J Theor Biol 2017
Jie Zhang, Angela G Fleischman, Dominik Wodarz, Natalia L Komarova. J Theor Biol 2017
25
The mathematics of cancer: integrating quantitative models.
Philipp M Altrock, Lin L Liu, Franziska Michor. Nat Rev Cancer 2015
Philipp M Altrock, Lin L Liu, Franziska Michor. Nat Rev Cancer 2015
25
Bridging blood cancers and inflammation: The reduced Cancitis model.
Johnny T Ottesen, Rasmus K Pedersen, Zamra Sajid, Johanne Gudmand-Hoeyer, Katrine O Bangsgaard, Vibe Skov, Lasse Kjær, Trine A Knudsen, Niels Pallisgaard, Hans C Hasselbalch,[...]. J Theor Biol 2019
Johnny T Ottesen, Rasmus K Pedersen, Zamra Sajid, Johanne Gudmand-Hoeyer, Katrine O Bangsgaard, Vibe Skov, Lasse Kjær, Trine A Knudsen, Niels Pallisgaard, Hans C Hasselbalch,[...]. J Theor Biol 2019
25
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera.
Ann Mullally, Claudia Bruedigam, Luke Poveromo, Florian H Heidel, Amy Purdon, Therese Vu, Rebecca Austin, Dirk Heckl, Lawrence J Breyfogle, Catherine Paine Kuhn,[...]. Blood 2013
Ann Mullally, Claudia Bruedigam, Luke Poveromo, Florian H Heidel, Amy Purdon, Therese Vu, Rebecca Austin, Dirk Heckl, Lawrence J Breyfogle, Catherine Paine Kuhn,[...]. Blood 2013
25
Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial.
Lucia Masarova, Keyur P Patel, Kate J Newberry, Jorge Cortes, Gautam Borthakur, Marina Konopleva, Zeev Estrov, Hagop Kantarjian, Srdan Verstovsek. Lancet Haematol 2017
Lucia Masarova, Keyur P Patel, Kate J Newberry, Jorge Cortes, Gautam Borthakur, Marina Konopleva, Zeev Estrov, Hagop Kantarjian, Srdan Verstovsek. Lancet Haematol 2017
25
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
Magnus Björkholm, Asa R Derolf, Malin Hultcrantz, Sigurdur Y Kristinsson, Charlotta Ekstrand, Lynn R Goldin, Björn Andreasson, Gunnar Birgegård, Olle Linder, Claes Malm,[...]. J Clin Oncol 2011
Magnus Björkholm, Asa R Derolf, Malin Hultcrantz, Sigurdur Y Kristinsson, Charlotta Ekstrand, Lynn R Goldin, Björn Andreasson, Gunnar Birgegård, Olle Linder, Claes Malm,[...]. J Clin Oncol 2011
25
Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study.
M Michallet, F Maloisel, M Delain, A Hellmann, A Rosas, R T Silver, C Tendler. Leukemia 2004
M Michallet, F Maloisel, M Delain, A Hellmann, A Rosas, R T Silver, C Tendler. Leukemia 2004
25
Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.
H Vaziri, W Dragowska, R C Allsopp, T E Thomas, C B Harley, P M Lansdorp. Proc Natl Acad Sci U S A 1994
H Vaziri, W Dragowska, R C Allsopp, T E Thomas, C B Harley, P M Lansdorp. Proc Natl Acad Sci U S A 1994
25
Dynamics of chronic myeloid leukaemia.
Franziska Michor, Timothy P Hughes, Yoh Iwasa, Susan Branford, Neil P Shah, Charles L Sawyers, Martin A Nowak. Nature 2005
Franziska Michor, Timothy P Hughes, Yoh Iwasa, Susan Branford, Neil P Shah, Charles L Sawyers, Martin A Nowak. Nature 2005
25
Punctuated evolution of prostate cancer genomes.
Sylvan C Baca, Davide Prandi, Michael S Lawrence, Juan Miguel Mosquera, Alessandro Romanel, Yotam Drier, Kyung Park, Naoki Kitabayashi, Theresa Y MacDonald, Mahmoud Ghandi,[...]. Cell 2013
Sylvan C Baca, Davide Prandi, Michael S Lawrence, Juan Miguel Mosquera, Alessandro Romanel, Yotam Drier, Kyung Park, Naoki Kitabayashi, Theresa Y MacDonald, Mahmoud Ghandi,[...]. Cell 2013
25
A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.
Tomoko Saito, Atsushi Niida, Ryutaro Uchi, Hidenari Hirata, Hisateru Komatsu, Shotaro Sakimura, Shuto Hayashi, Sho Nambara, Yosuke Kuroda, Shuhei Ito,[...]. Nat Commun 2018
Tomoko Saito, Atsushi Niida, Ryutaro Uchi, Hidenari Hirata, Hisateru Komatsu, Shotaro Sakimura, Shuto Hayashi, Sho Nambara, Yosuke Kuroda, Shuhei Ito,[...]. Nat Commun 2018
25
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Kroopa Joshi, Marc Robert de Massy, Mazlina Ismail, James L Reading, Imran Uddin, Annemarie Woolston, Emine Hatipoglu, Theres Oakes, Rachel Rosenthal, Thomas Peacock,[...]. Nat Med 2019
Kroopa Joshi, Marc Robert de Massy, Mazlina Ismail, James L Reading, Imran Uddin, Annemarie Woolston, Emine Hatipoglu, Theres Oakes, Rachel Rosenthal, Thomas Peacock,[...]. Nat Med 2019
25
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Marco Gerlinger, Andrew J Rowan, Stuart Horswell, M Math, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart,[...]. N Engl J Med 2012
Marco Gerlinger, Andrew J Rowan, Stuart Horswell, M Math, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart,[...]. N Engl J Med 2012
25
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.
Khurum H Khan, David Cunningham, Benjamin Werner, Georgios Vlachogiannis, Inmaculada Spiteri, Timon Heide, Javier Fernandez Mateos, Alexandra Vatsiou, Andrea Lampis, Mahnaz Darvish Damavandi,[...]. Cancer Discov 2018
Khurum H Khan, David Cunningham, Benjamin Werner, Georgios Vlachogiannis, Inmaculada Spiteri, Timon Heide, Javier Fernandez Mateos, Alexandra Vatsiou, Andrea Lampis, Mahnaz Darvish Damavandi,[...]. Cancer Discov 2018
25
Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer.
Marlon Perera, Matthew J Roberts, Laurence Klotz, Celestia S Higano, Nathan Papa, Shomik Sengupta, Damien Bolton, Nathan Lawrentschuk. Nat Rev Urol 2020
Marlon Perera, Matthew J Roberts, Laurence Klotz, Celestia S Higano, Nathan Papa, Shomik Sengupta, Damien Bolton, Nathan Lawrentschuk. Nat Rev Urol 2020
25
Spatially resolved transcriptomics and its applications in cancer.
Silas Maniatis, Joana Petrescu, Hemali Phatnani. Curr Opin Genet Dev 2021
Silas Maniatis, Joana Petrescu, Hemali Phatnani. Curr Opin Genet Dev 2021
25
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.
Marco Gerlinger, Stuart Horswell, James Larkin, Andrew J Rowan, Max P Salm, Ignacio Varela, Rosalie Fisher, Nicholas McGranahan, Nicholas Matthews, Claudio R Santos,[...]. Nat Genet 2014
Marco Gerlinger, Stuart Horswell, James Larkin, Andrew J Rowan, Max P Salm, Ignacio Varela, Rosalie Fisher, Nicholas McGranahan, Nicholas Matthews, Claudio R Santos,[...]. Nat Genet 2014
25
Origins of lymphatic and distant metastases in human colorectal cancer.
Kamila Naxerova, Johannes G Reiter, Elena Brachtel, Jochen K Lennerz, Marc van de Wetering, Andrew Rowan, Tianxi Cai, Hans Clevers, Charles Swanton, Martin A Nowak,[...]. Science 2017
Kamila Naxerova, Johannes G Reiter, Elena Brachtel, Jochen K Lennerz, Marc van de Wetering, Andrew Rowan, Tianxi Cai, Hans Clevers, Charles Swanton, Martin A Nowak,[...]. Science 2017
25
Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer.
Pedro M Enriquez-Navas, Yoonseok Kam, Tuhin Das, Sabrina Hassan, Ariosto Silva, Parastou Foroutan, Epifanio Ruiz, Gary Martinez, Susan Minton, Robert J Gillies,[...]. Sci Transl Med 2016
Pedro M Enriquez-Navas, Yoonseok Kam, Tuhin Das, Sabrina Hassan, Ariosto Silva, Parastou Foroutan, Epifanio Ruiz, Gary Martinez, Susan Minton, Robert J Gillies,[...]. Sci Transl Med 2016
25
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.